Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 28Terminated 8Unknown 3Active not recruiting 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 49NIH 29INDUSTRY 3NETWORK 1INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Psoriasis 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoma, Follicular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Injections 54Cisplatin 49Paclitaxel 48Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 36Capecitabine 36Drug Therapy 34anlotinib 25Bevacizumab 25Fluorouracil 24Cyclophosphamide 24icotinib 23Oxaliplatin 20fludarabine 19Pemetrexed 17Leucovorin 16Irinotecan 16Temozolomide 14Nivolumab 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Methotrexate × Clear all
NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown
150 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT05751512 2023-03-02

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Shanghai Miracogen Inc.

Phase 3 Unknown
180 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03424629 2018-04-20

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Tianjin Ever Union Biotechnology Co., Ltd.

Phase 1 Unknown
57 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡